CAREBOT

Radiology departments face a structural mismatch between rising imaging volumes and a limited number of qualified radiologists. The result is longer reporting times, growing reading backlogs, and pressure that can contribute to overlooked or delayed findings on routine examinations such as chest X-rays.

Because X-ray remains the most frequent imaging modality in primary and emergency care, even small per-study inefficiencies aggregate into significant clinical and operational impact. Subtle pathologies are easy to miss under workload pressure, and inconsistent reporting quality between sites and shifts adds further risk.

Hospitals and imaging providers need tools that reduce reading time and the risk of missed findings without disrupting existing workflows or shifting clinical responsibility away from the radiologist.

Carebot develops AI software that assists radiologists in the analysis of medical imaging data, primarily X-ray scans. The system automatically detects and highlights potential pathological findings, prioritizes suspicious studies, and produces structured outputs that fit into the radiologist's reporting routine.

The product is positioned as a clinical decision support tool, not an autonomous reader: the final diagnostic decision remains with the physician. By flagging abnormalities and ordering worklists by suspected severity, Carebot supports earlier detection and more consistent reporting across shifts and sites.

The underlying technology is based on proprietary deep-learning models trained on large, curated medical image datasets, with an explicit focus on explainability, robustness, and clinical relevance. Continuous in-house model development keeps the system aligned with new diagnostic indications and regulatory expectations.

A key differentiator is seamless integration into existing hospital IT systems, which allows scalable deployment without disrupting established radiology workflows or requiring new reading software for clinicians.

Carebot operates as a B2B software vendor to healthcare providers, primarily hospitals and radiology departments that run high volumes of X-ray imaging. The product is delivered as clinical decision support software that integrates into existing radiology IT infrastructure rather than as a standalone reading platform.

Given the regulated nature of medical-device software and the integration-heavy deployment model, the natural commercial channels are direct sales to hospital networks and imaging providers, complemented by partnerships with PACS and radiology IT vendors that already sit inside customer environments.

Specific pricing, contract structure, and partner arrangements are not disclosed in this bundle.

Carebot addresses the medical imaging AI segment, focused on radiology and specifically on X-ray-based diagnostic support. The target customers are hospitals, radiology clinics, and imaging service providers whose workload and staffing constraints create demand for AI-assisted reading.

The company is headquartered in Prague and is at the commercial stage, with the product deployed in clinical use rather than confined to research or pilot settings. This places Carebot among medical-device software vendors that have cleared the regulatory and integration hurdles typical of the radiology AI market.

Adjacent positioning within the broader Health and Artificial Intelligence categories means the relevant buyer landscape spans clinical leadership, hospital IT, and procurement, with growth tied to expanding the set of supported diagnostic indications and customer sites.